2020-05-01ãã1ã¶æéã®è¨äºä¸è¦§
西浦å çãæ¥æ¬ã®å®å¹åçç£æ°ãæ¨å®ããã ã³ã¼ãã¯rstanã§ä¸è¨ããåããã https://nbviewer.jupyter.org/github/contactmodel/COVID19-Japan-Reff/tree/master/解説åç»ãè¦éããã®ã§ã³ã¼ãã¨é¢é£è«æããã®ãåå¼·ã«ãªãããèã¨ãã¦ã¯ã ã»ç¥ãããã®â¦
山梨大å¦å»å¦é¨éå±ç é¢ã§ãæ ¶å¿å¤§å¦ç é¢ã¨åãããã«å ¥é¢ä¸ã®æ£è ã«PCRæ¤æ»ãè¡ãã¨ã370人ä¸å ¨å¡ãé°æ§ã ã£ããããã 山梨大ç é¢ããã¹ã¦ã®å ¥é¢æ£è ãã«PCRæ¤æ» å ¨å¡é°æ§ [æ°åã³ããã¦ã¤ã«ã¹]ï¼ææ¥æ°èãã¸ã¿ã« 山梨大ã®å³¶ç°çè·¯å¦é·ã¯ãé½æ§è ãããå ´â¦
ãããªãã¨ãããã mikuhatsune.hatenadiary.com éä¸æ²»çå¦ä¼ãã人工å¼å¸å¨ãè¦ãã¦ããæ£è ãECMOããã¦ããæ£è ãECMOã§æ»äº¡ããæ£è ãECMOããå復ããæ£è ããªã©æ¥ãã¼ã¹ã§å ¬éãã¦ãã ããã«ãæ¯æ¥ã®ææè ãæ»äº¡è ã®ãã¼ã¿ããã£ã¤ãã¦ãSIRã使ã£â¦
ãããªãã¼ã¿ãããã covid19.jsicm.org COVID-19ã«ããå ¨å½ã®äººå·¥å¼å¸å¨æ£è æ°ã¨ECMO稼åæ°ï¼ã¨é¢è±è æ°ãæ»äº¡è æ°ãç¾å¨ãæ²»çããã¦ããæä¸ã®æ°ï¼ãjsã§ã°ãªã°ãªã§ããã ã°ãªã°ãªã§ããã®ã¯ãããã47é½éåºç+å°æ¹å¥ã¨ãã¼ã¿ãåãã®ãé¢åãªã®ã§ãå¼â¦
èªãã ã Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study. | medRxiv ç¥æ¸å¸ã®å ¥é¢ä¸ã®æ£è ã§ãå ¥é¢ä¸ã®æ¤æ»ãé©å½ï¼ã©ã³ãã ãµã³ããªã³â¦
çµè«ããè¨ãã¨ãæä½æ¤æ»ãåãã202人ã®éå£ã«ããã¦ã9.4%ï¼95% ä¿¡ç¨åºéã§5.4%ã13.9%ï¼ãææè ã§ããããã ãããã®æä½æ¤æ»ãåãã202人ã¯ãæ±äº¬é½ï¼ã¨ãä»ã®é½éåºçä¸è¬ï¼ã®ã©ã³ãã ãµã³ããªã³ã°ã¨ã¯è¨ããªãã®ã§ãåç´ã«æ±äº¬é½äººå£ã®9.4%ãææãâ¦